Evidence map›Paper›PMID 30555465›Full record

SynthesisFrontiers in immunology2018

Mechanisms and Functions of Chemerin in Cancer: Potential Roles in Therapeutic Intervention.

Woo Jae Shin, Brian A Zabel, Russell K Pachynski

Open access · goldAbstract readSystematic Review
In one paragraph

Synthesis in Frontiers in immunology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 51 papers.

0numbers the graph read from it
0cells of the map it votes in
51citing papers in PubMed
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

51 citing papers in PubMed, 70 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Review
  12. Review
  13. Review
  14. Review
  15. Article
  16. Article
  17. Review
  18. Chemerin triggers migration of a CD8 T cell subset with natural killer cell functions.Molecular therapy : the journal of the American Society of Gene Therapy · 2023
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Woo Jae ShinDivision of Oncology, Washington University School of Medicine, St. Louis, MO, United States.
Brian A ZabelPalo Alto Veterans Institute for Research (PAVIR), VA Palo Alto Health Care Systems (VAPAHCS), Palo Alto, CA, United States.
Russell K PachynskiDivision of Oncology, Washington University School of Medicine, St. Louis, MO, United States.
Washington University in St. Louis · USVA Palo Alto Health Care System · US

Funding

Molecular and Functional Characterization of Chemerin ReceptorsR01AI079320 · NIAID · PALO ALTO VETERANS INSTIT FOR RESEARCH · PI ZABEL, BRIAN A. · 2009 to 2013
$1.7M
Chemerin in Tumor Immunity and SurveillanceR01CA169354 · NCI · PALO ALTO VETERANS INSTIT FOR RESEARCH · PI BUTCHER, EUGENE C · 2013 to 2017
$1.7M
NCI NIH HHS R01 CA169354NIAID NIH HHS R01 AI079320
6 · The paper itself

Abstract

Chemerin [

Indexed as

AnimalsChemokinesDendritic CellsDown-RegulationGene Expression Regulation, NeoplasticHumansIntercellular Signaling Peptides and ProteinsKiller Cells, NaturalMacrophagesNeoplasm ProteinsNeoplasmsReceptors, ChemokineChemokinesCMKLR1 protein, humanIntercellular Signaling Peptides and ProteinsNeoplasm ProteinsRARRES2 protein, humanReceptors, ChemokinecancerCCRL2chemerinchemoattractantCMKLR1cytokineGPR1RARRES2

Identifiers

PMID30555465
PMCPMC6283908
OpenAlexW2902283448

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.